Emmaus Life Sciences Inc
OTC:EMMA

Watchlist Manager
Emmaus Life Sciences Inc Logo
Emmaus Life Sciences Inc
OTC:EMMA
Watchlist
Price: 0.0137 USD Market Closed
Market Cap: 875k USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

EMMA Price Targets Summary
Emmaus Life Sciences Inc

There are no price targets for EMMA.
EMMA Lowest Forecast
Wall Street Target
Not Available
EMMA Average Forecast
Wall Street Target
Not Available
EMMA Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Emmaus Life Sciences Inc Competitors:
Price Targets
ROVI
Laboratorios Farmaceuticos ROVI SA
50% Upside
688578
Shanghai Allist Pharmaceuticals Co Ltd
5% Upside
600216
Zhejiang Medicine Co Ltd
12% Upside
4568
Daiichi Sankyo Co Ltd
61% Upside
ROVI
Laboratorios Farmaceuticos ROVI SA
50% Upside
688578
Shanghai Allist Pharmaceuticals Co Ltd
5% Upside
600216
Zhejiang Medicine Co Ltd
12% Upside
4568
Daiichi Sankyo Co Ltd
61% Upside
PSG
PharmaSGP Holding SE
40% Upside
C
300765
CSPC Innovation Pharmaceutical Co Ltd
12% Downside
300705
Hunan Jiudian Pharmaceutical Co Ltd
78% Upside
VRNA
Verona Pharma PLC
3% Upside

Revenue
Forecast

Revenue Estimate
Emmaus Life Sciences Inc

For the last 8 years the compound annual growth rate for Emmaus Life Sciences Inc's revenue is 92%. The projected CAGR for the next 1 year is 40%.

92%
Past Growth
40%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Emmaus Life Sciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
20%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Emmaus Life Sciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
EMMA intrinsic value, competitors valuation, and company profile.
DCF Valuation
EMMA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EMMA stock valuation using valuation multiples.
Wall Street Estimates
EMMA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EMMA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EMMA's stock price target?
Not Available

EMMA doesn't have any price targets made by Wall Street professionals.

What is Emmaus Life Sciences Inc's Revenue forecast?
Projected CAGR
40%

For the last 8 years the compound annual growth rate for Emmaus Life Sciences Inc's revenue is 92%. The projected CAGR for the next 1 year is 40%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 268,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.